Literature DB >> 7934167

Increased serum levels of C-terminal parathyroid hormone-related protein in different diseases associated with HTLV-1 infection.

K Yamaguchi1, T Kiyokawa, T Watanabe, T Ideta, K Asayama, M Mochizuki, A Blank, K Takatsuki.   

Abstract

We analyzed the serum levels of C-terminal parathyroid hormone-related protein (C-PTHrP) in asymptomatic carriers of human T lymphotropic virus type 1 (HTLV-1) and patients with three HTLV-1 related diseases; adult T-cell leukemia (ATL), HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and HTLV-1 uveitis (HU). Serum C-PTHrP levels were significantly elevated in HTLV-1-infected individuals, irrespective of whether they were symptomatic or asymptomatic, when compared with that of the seronegative controls. In ATL patients, a good correlation was demonstrated between the serum C-PTHrP level and serum calcium or lactic dehydrogenase (LDH) level. Thus the elevated serum C-PTHrP level could be a characteristic marker of HTLV-1 carrier state, and the determination of its level in ATL patients could be useful for the assessment of the prognosis and as one of the tumor markers. The determination of the serum level of C-PTHrP in various stages of the HTLV-1 carrier state would help to understand the mechanism of the development of hypercalcemia in ATL.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7934167

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro.

Authors:  Sherry T Shu; Wessel P Dirksen; Lisa G Lanigan; Chelsea K Martin; Nanda K Thudi; Jillian L Werbeck; Soledad A Fernandez; Blake E Hildreth; Thomas J Rosol
Journal:  Leuk Lymphoma       Date:  2012-01-03

2.  Novel B-cell acute lymphoblastic leukemia sister cell lines BALM 19-23 and BALM-26 with interclonal proliferative and phenotypic heterogeneity from a patient with hypercalcemia.

Authors:  Yoshinobu Matsuo; Hans G Drexler; Kensuke Kojima; Akira Sugimoto; Akira Harashima; Ayumi Okochi; Masamichi Hara; Kunzo Orita
Journal:  Hum Cell       Date:  2002-09       Impact factor: 4.174

3.  Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors.

Authors:  Nicole A Kohart; Said M Elshafae; Aylin A Demirer; Wessel P Dirksen; Justin T Breitbach; Sherry T Shu; Jingyu Xiang; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Leuk Lymphoma       Date:  2019-10-08

4.  A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.

Authors:  Sherry T Shu; Murali V P Nadella; Wessel P Dirksen; Soledad A Fernandez; Nanda K Thudi; Jillian L Werbeck; Michael D Lairmore; Thomas J Rosol
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

5.  Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone.

Authors:  Nicole A Kohart; Said M Elshafae; Wachirapan Supsahvad; Aylin Alasonyalilar-Demirer; Amanda R Panfil; Jingyu Xiang; Wessel P Dirksen; Deborah J Veis; Patrick L Green; Katherine N Weilbaecher; Thomas J Rosol
Journal:  J Bone Oncol       Date:  2019-08-20       Impact factor: 4.072

6.  Molecular hallmarks of adult T cell leukemia.

Authors:  Makoto Yamagishi; Toshiki Watanabe
Journal:  Front Microbiol       Date:  2012-09-17       Impact factor: 5.640

7.  Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.

Authors:  Masachika Senba; Kioko Kawai; Naoki Mori
Journal:  Leuk Res Treatment       Date:  2011-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.